2025. Bimekizumab-induced eczematous eruption treated successfully with sequential upadacitinib and dupilumab therapy. SKIN The Journal of Cutaneous Medicine. 9, 3 (May 2025), 2330–2333. DOI:https://doi.org/10.25251/skin.9.3.8.